Grantham, Mayo, Van Otterloo & Co. LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1352662
Boston, MA
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$46,266,668
+$3,498,727 QoQ
Shares Held
74,200
+34.0% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#131
of 1,328 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Grantham, Mayo, Van Otterloo & Co. LLC holds $101,442,658 across 6 Biotechnology names. REGN ranks #1 (45.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
74,200 | $46,266,668 | |
| 2 | INCY |
Incyte Corp
|
318,584 | $36,114,682 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
137,395 | $18,236,438 | |
| 4 | HRMY |
Harmony Biosciences Holdings, Inc.
|
10,891 | $396,541 | |
| 5 | ALT |
Altimmune, Inc.
|
83,837 | $254,864 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
|
28,344 | $173,465 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,266,668 | 74,200 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $42,767,941 | 55,353 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $43,768,116 | 56,704 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $34,564,985 | 61,474 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $34,273,575 | 65,283 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $52,850,385 | 83,330 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $44,861,831 | 62,979 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $54,661,326 | 51,997 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $60,186,181 | 57,264 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $55,689,671 | 57,860 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $58,933,259 | 67,100 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $47,682,302 | 57,940 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $38,013,640 | 52,904 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $55,168,567 | 67,142 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $51,328,241 | 71,142 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $37,198,980 | 54,000 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $33,339,732 | 56,400 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $33,454,318 | 47,900 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $29,934,048 | 47,400 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $29,835,374 | 49,300 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $27,089,190 | 48,500 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $19,682,624 | 41,600 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $13,602,445 | 28,156 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $255,259 | 456 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $284,384 | 456 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||